ADVAMED LTR to FDA CDRH Director on Part 11

ADVAMED and NEMA sent a letter to Dr. Feigal (Director of FDA’s Device Center) raising concerns about Part 11 based on a recent meeting with FDA.
They are objecting to the return of Part 11 responsibility to the drug center with no formal device center involvement and the potential that the drug center will issue a new guidance in final form without going through a draft review process with industry.

The full letter is at the link provided.  Advamed-NEMAPart11Ltr2DrFeigal021203

Schedule Discussion with John F. Murray, Jr.

John is currently providing telephone and face-to-face meetings to discuss:  Cybersecurity, Part 11, 483 Response, design controls expectations for software documentation, and other topics.

Leave a message and we will contact you to schedule:

Corporate Office

+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TN) and Italy.